ReviewDer Pathologe2015

[Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

E Dahl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.